Harvard Bioscience, Inc. (HBIO) fundamentals score
Harvard Bioscience, Inc., a Delaware corporation, is a leading developer, manufacturer and seller of technologies, products and services that enable fundamental advances in life science applications, including research, drug and therapy discovery, bioproduction and preclinical testing for pharmaceutical and therapy development.
Laboratory Analytical Instruments · Technology · Listed on NASDAQ
Overall: 5.3 out of 10, Mixed fundamentals
- Growth: 5.1/10
- Profitability: 4.8/10
- Financial health: 4.5/10
- Earnings quality: 9.0/10
- Valuation: 3.7/10
Scores are calculated from Harvard Bioscience, Inc.’s SEC filings, using the 12 months through 2026-06. Compare it with past big winners, check its flags, and see today’s price against its fundamentals in the full scorecard.
Other Technology stocks
- Micron Technology, Inc. (MU): 9.0/10
- Broadcom Inc. (AVGO): 8.9/10
- Logitech International S.A. (LOGI): 8.8/10
- Applovin Corporation (APP): 8.7/10
- Cirrus Logic, Inc. (CRUS): 8.7/10
- Hamilton Beach Brands Holding Company (HBB): 8.7/10
- Nerdwallet, Inc. (NRDS): 8.7/10
- Sandisk Corporation (SNDK): 8.7/10